SelectScience InterviewsLife Sciences

Better Development of Pharmaceuticals and Diagnostics with the bScreen from Berthold Technologies

26 Oct 2015
Better Development of Pharmaceuticals and Diagnostics with the bScreen from Berthold Technologies

At Biotechnica 2015, Dr. Frank Schleifenbaum, Marketing and Product Management at Berthold Technologies, introduced the bScreen LB 991, a label-free microarray reader capable of providing full kinetic analysis on up to 20,000 interactions in a single run. Using a standard microarray format, you can screen a library full of interaction partners with high throughput, ideal for pharmaceutical small molecular screening, epitope mapping and diagnostic testing.

Other videos from SelectScience

Links